Coley Fluid: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{ | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 13: | Line 13: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
{{SIB}} | {{SIB}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} |
Revision as of 22:07, 20 January 2012
WikiDoc Resources for Coley Fluid |
Articles |
---|
Most recent articles on Coley Fluid Most cited articles on Coley Fluid |
Media |
Powerpoint slides on Coley Fluid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Coley Fluid at Clinical Trials.gov Clinical Trials on Coley Fluid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Coley Fluid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Coley Fluid Discussion groups on Coley Fluid Patient Handouts on Coley Fluid Directions to Hospitals Treating Coley Fluid Risk calculators and risk factors for Coley Fluid
|
Healthcare Provider Resources |
Causes & Risk Factors for Coley Fluid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Coley Fluid is a modern reformulation of a historical cancer therapy called Coley Vaccine developed by Dr. William B. Coley that was an effective treatment for many forms of cancer including advanced breast cancer.
The authors of a 1982 study concluded five year survival rates of historical Coley Vaccine patients is indistinguishable from five-year survival of modern patients.
In 1999, researchers found ten-year survival was higher in historical Coley Vaccine patients compared to modern sarcoma, kidney and ovarian cancer patients.
Coley Fluid is manufactured by MBVax Bioscience Inc, Ancaster, Canada.